Tibud, Lolly S.
HRN: 06-47-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2024
MUPIROCIN 2%, 15G (TUBE)
02/19/2024
02/26/2024
TOPICAL
Sufficient Amount
TID
Pressure Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes